Patents for A61P 19 - Drugs for skeletal disorders (81,981)
06/2010
06/23/2010CN101744896A Traditional Chinese medicine for warming and activating meridian, reducing swelling and easing pain and treating osteopathy
06/23/2010CN101744895A Medical preparation for treatment of rheumatism, lumbar vertebra disease and cervical spondylosis
06/23/2010CN101744875A Lamiophlomis rotata traditional chinese medicine and preparation method thereof
06/23/2010CN101744861A Plaster for treating hyperostosis
06/23/2010CN101744860A Plaster for treating hyperostosis
06/23/2010CN101744841A Collins john kevin; o'sullivan gerald christopher; o'mahony liam; shanahan fergus
06/23/2010CN101744835A Tungstenic compound nutriment for preventing and treating calculus and gout class diseases of urinary system
06/23/2010CN101744285A Method for preparing emulsified and gelatinized functional fatty acid carrier
06/23/2010CN101249203B Traditional Chinese medicine for curing acute and chronic waist-leg pain and lumbar intervertebral disc bulge bone fracture dislocation
06/23/2010CN101229313B Hotspring powder medicine compounds
06/23/2010CN101199707B Bone-knitting plaster for treating fracture and preparing method thereof
06/23/2010CN101199601B Naze rheumatism medicated liquor
06/23/2010CN101181487B Chinese medicine composition orally taken for curing osteosporosis
06/23/2010CN101161274B A Chinese medicine composition for treating gout
06/23/2010CN101161273B A Chinese patent medicine for treating catagmat
06/23/2010CN101156920B Oral administration and externally used drug for treating traumatic injury and its preparation method
06/23/2010CN101156901B An externally used traditional Chinese medicine preparation for treating rheumatism and rheumatoid as well as its preparation method
06/23/2010CN101138597B Traditional Chinese medicine preparation for preventing and controlling osteoporosis and method of preparing the same
06/23/2010CN101040986B Chinese traditional medicine compound took orally for treating cervical spondylotic radiculopathy
06/22/2010US7741452 produced by introducing amino acid mutation(s) so that no glycosylation take place at at least one glycosylation site of hepatocyte growth factor; more stable in the blood circulation
06/22/2010US7741335 administering nontoxic, preferential and potent c-kit ligand inhibitors such as imatinib, to humans for treatment of inflammatory diseases such as rheumatoid arthritis
06/22/2010US7741329 such as 1-{(S)-2-[(5-Bromo-pyrimidin-2-ylamino)-methyl]-piperidin-1-yl}-1-quinolin-2-yl-methanone, used as human orexin receptor antagonist, for the treatment of obesity and insomnia
06/22/2010US7741312 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries
06/22/2010US7741282 Apo2L/TRAIL formulations including lyophilized and crystal compositions; may be used in inducing apoptosis in mammalian cells including cancer cells by exposing mammalian cells to an effective amount of an Apo-2 ligand formulation described herein
06/22/2010US7741278 Modified proteins, designer toxins, and methods of making thereof
06/22/2010US7741057 Method for screening for compounds using MHC class II invariant chain polypeptide and macrophage migration inhibitory factor
06/22/2010US7741030 detecting whether CpG sequences in a region from base 374 to base 592 in a DR3 gene promoter region obtained from synovial cells or synovial infiltrating lymphocytes of the human subject are methylated or not
06/22/2010US7740854 Treatment of macrophage mediated disease
06/22/2010US7740834 Murine zcytor17 ligand polypeptides
06/22/2010CA2586538C Nitroxy steroids
06/22/2010CA2480409C Novel pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
06/22/2010CA2406177C 8.beta.-hydrocarbyl-substituted estratrienes as selectively active estrogens
06/22/2010CA2323073C Uses for human non-autologous mesenchymal stem cells
06/17/2010WO2010068810A2 Certain substituted amides, method of making, and method of use thereof
06/17/2010WO2010068105A1 Nutritional compositions with large lipid globule size
06/17/2010WO2010068103A1 Nutritional compositions with coated lipid globules
06/17/2010WO2010068086A1 Nutritional compositions with large lipid globule size
06/17/2010WO2010067339A2 Fusion protein capable of binding vegf-a and tnf-alpha
06/17/2010WO2010025436A3 Nitrogen and sulfur-containing heterocycle derivatives
06/17/2010WO2010025295A3 Compounds that modulate intracellular calcium
06/17/2010WO2010025135A3 Trimeprazine and ethopropazine derivatives for promoting bone growth
06/17/2010WO2010022043A3 Targeting of histone deacetylase 2 and protein kinase ck2 for treatment of inflammatory diseases
06/17/2010WO2010007168A3 Treatment of rheumatoid arthritis with mammal beta defensins
06/17/2010WO2009158480A3 Stimulation of cartilage formation using reduced pressure treatment and chondrocytes
06/17/2010US20100152863 Bioactive Grafts and Composites
06/17/2010US20100152305 Methods of treatment of hyperuricemia and associated disease states
06/17/2010US20100152271 Estrogen receptor modulators and uses thereof
06/17/2010US20100152255 Organic Compounds
06/17/2010US20100152240 Pyrroline-2-one derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof
06/17/2010US20100152236 Cyclic amine compound
06/17/2010US20100152211 Inhibitors of human phosphatidylinositol 3-kinase delta
06/17/2010US20100152209 Compounds for Modulating TRPV3 Function
06/17/2010US20100152192 Fused imidazole carboxamides as trpv3 modulators
06/17/2010US20100152186 Triazolyl pyridyl benzenesulfonamides
06/17/2010US20100152178 Imidazole derivatives
06/17/2010US20100152167 Pyrimidine derivatives
06/17/2010US20100152155 Histone Deacetylase Inhibitors
06/17/2010US20100152148 Novel compounds
06/17/2010US20100152112 Quinoline derivatives as p13 kinase inhibitors
06/17/2010US20100152099 Macrocyclic compounds for inhibition of tumor necrosis factor alpha
06/17/2010US20100151063 Serum uric acid level-decreasing agent and food and drink with label telling that food and drink decrease serum uric acid level
06/17/2010US20100151034 Granular pharmaceutical composition of atorvastatin for oral administration
06/17/2010US20100151025 Prevention and treatment for osteonecrosis and osteoradionecrosis of the jaw
06/17/2010US20100151007 Compositions and methods for selective inhibition of vegf
06/17/2010US20100150926 Fusion protein capable of binding vegf-a and tnf-alpha
06/17/2010US20100150908 Affinity matured CRIg variants
06/17/2010US20100150893 Methods of organ regeneration
06/17/2010US20100150888 Cells for joint fluid
06/17/2010US20100150881 Compositions and Methods for Use of Scar Tissue in Repair of Weight Bearing Surfaces
06/17/2010US20100150872 Polypeptides derived from the hemopexin-like domain of metalloproteinase mmp-2
06/17/2010CA2734283A1 Inhalant formulations comprising a bisphosphonate and a pyrazolone derivative and methods for using the same
06/16/2010EP2196538A1 Conjugates prepared with aggregate-free proteins
06/16/2010EP2196475A1 INTERFERON ALPHA 2a MODIFIED BY POLYETHYLENE GLYCOL, ITS SYNTHESIS PROCESS AND APPLICATION
06/16/2010EP2196218A2 Use of anti-TNFalpha antibodies and another drug
06/16/2010EP2195026A2 Method for inhibiting bone resorption
06/16/2010EP1645566B1 Analogs of parathyroid hormone
06/16/2010EP1625847B1 Medical use of a tetrahydrotriazolo[4,3-a]pyrazine
06/16/2010CN1921847B Amino alcohol compound
06/16/2010CN1774428B M-stage kinesin inhibitor
06/16/2010CN101743254A Antigen binding proteins that bind PAR-2
06/16/2010CN101742993A Axomadol for treating pain from arthritis
06/16/2010CN101735991A Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
06/16/2010CN101735306A Anti-inflammatory peptide with membrane penetration effect
06/16/2010CN101735271A Bong-seeking bisphosphonate rhein ester derivates and preparation method thereof
06/16/2010CN101735218A Piperidine carbamic acid ester derivative and application thereof
06/16/2010CN101732728A Anti-inflammatory drug (polysaccharide conjugate) as well as preparation and application of drug composition thereof
06/16/2010CN101732697A Compound frozen ossotide preparation
06/16/2010CN101732693A External self-heating patch for treating protrusion of lumbar vertebral disc
06/16/2010CN101732691A Externally applied medicament for preventing and/or treating spondylodynia, osteoarthrosis and gout
06/16/2010CN101732680A Medicinal composition for treating cervical spondylosis
06/16/2010CN101732677A Formula of Chinese medicament for curing rheumatoid diseases
06/16/2010CN101732661A Chinese medicament for treating fracture
06/16/2010CN101732658A Chinese medicament for treating scapulohumeral periarthritis
06/16/2010CN101732654A External mixture for treating rheumatism and bone disease and preparation method thereof
06/16/2010CN101732653A Medicament for curing senile cervical and lumbar vertebra diseases
06/16/2010CN101732649A Chinese medicament for treating rickets
06/16/2010CN101732648A Medicament for treating nonunion
06/16/2010CN101732623A Medicament for treating acute gouty arthritis and preparation method thereof
06/16/2010CN101732619A Ointment for activating meridians to stop pain
06/16/2010CN101732618A Medicament for curing arthromeningitis and preparation process